The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure (RAD HF)

This study is currently recruiting participants.
Verified June 2013 by Intermountain Health Care, Inc.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Intermountain Health Care, Inc.
ClinicalTrials.gov Identifier:
NCT01887353
First received: June 24, 2013
Last updated: February 7, 2014
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)